Despite efforts for improvement, the "State of the Air" report reveals concerns.

Published Date: 23 Apr 2023

Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.

Read Full News

Latest News

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Exploring First-Line Immunotherapy-Based Combinations in Advanced NSCLC

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

News All Time

Alzheimer's Risk May Be Influenced by Flu Shots

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia

Here's How Many Doctors and Nurses Are Getting Flu or COVID Shots

Nurses in particular do not seem to be fans of the COVID-19 vaccine

Trump: 'It Was Me as a Doctor'; Lululemon PFAS Probe; Dick Vitale's Fifth Cancer Dx

Health news and commentary gathered by MedPage Today staff

Quiz Time: How Are Flu Shots and Alzheimer's Linked?

You passed medical training, now see if you can pass our weekly quiz

Doc Detained by Border Patrol; Lady Gaga Sick, Cancels Show; Sexy Chocolate Recall

Health news and commentary gathered by MedPage Today staff

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says

Amoxicillin Alone Holds Up for Acute Sinusitis

Observational study supports efficacy, safety compared with amoxicillin-clavulanate

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Zongertinib in phase I trial showed sustained efficacy in aggressive disease

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Findings of TB DNA will require larger studies to confirm clinical relevance, says researcher

Congresswoman Tied to COVID Fraud Resigns; DOD Ends Flu Vax Mandate; USPSTF Overhaul

Health news and commentary gathered by MedPage Today staff

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

In a post-pandemic landscape, the drug didn't top usual care at stopping hospitalization, death

Bronchial Casts: An Unusual Complication of Wildfire Smoke Inhalation

Case is a "graphic demonstration" of emergent, severe impacts of forest fires for everyday people

Why Is a Healthy 22-Year-Old Male Suddenly Fainting and Short of Breath?

Careful questioning about patient's recent behaviors gave vital clue

Portable Tuberculosis Diagnostic Tool Matched Traditional Tests' Results

The MiniDock MTB could expand access to molecular testing in peripheral health centers

Symptoms, Radiologic Findings Point to COVID-19 -- but It's Not

Clue from a previous diagnosis of another disease?

Why Is Patient's Pneumonia Not Responding to Treatment?

Identifying one key measurement made all the difference

Recommended News For You

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

The need for more Latinx participants in Alzheimer's trials is urgent.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Recommended Articles For You

Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence 

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025 

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology 

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Interleukin-6 may boost prediction of obesity-related cancers

2.

Breast cancer screening in women's 40s can save lives, study says

3.

Higher levels of HIF2α found to slow down aggressive childhood cancer

4.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

5.

TULSA Is Effective in Long-Term Prostate Cancer Control.

1.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

2.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

3.

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights

4.

Stomach Cancer: Uncovering the Subtle Signs and Symptoms

5.

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

2.

Navigating the Complexities of Ph Negative ALL - Part XI

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot